“Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept” (2010) Farmeconomia. Health Economics and Therapeutic Pathways, 11(2), pp. 63–76. doi:10.7175/fe.v11i2.184.